|
Volumn 806, Issue 2, 2004, Pages 205-219
|
Validated semiquantitative/quantitative screening of 51 drugs in whole blood as silylated derivatives by gas chromatography-selected ion monitoring mass spectrometry and gas chromatography electron capture detection
|
Author keywords
Derivatization, GC; Drugs of abuse; Screening
|
Indexed keywords
BLOOD;
DERIVATIVES;
EXTRACTION;
GAS CHROMATOGRAPHY;
MASS SPECTROMETRY;
TOXIC MATERIALS;
ELECTRON CAPTURE DETECTION (ECD);
TOXICOLOGY;
DRUG PRODUCTS;
ANTICONVULSIVE AGENT;
ANTIDEPRESSANT AGENT;
BENZODIAZEPINE DERIVATIVE;
CANNABINOID;
CARISOPRODOL;
COCAINE;
FLURAZEPAM;
FLUVOXAMINE;
IMIPRAMINE;
LORAZEPAM;
MEPROBAMATE;
NEUROLEPTIC AGENT;
NITRAZEPAM;
OPIATE;
ORPHENADRINE;
OXAZEPAM;
PROMAZINE;
SERTRALINE;
TIZANIDINE;
TRIAZOLAM;
VENLAFAXINE;
ZALEPLON;
ZOLPIDEM;
ZOPICLONE;
ACCURACY;
ARTICLE;
BLOOD;
CALIBRATION;
CORRELATION COEFFICIENT;
DRUG BLOOD LEVEL;
DRUG ISOLATION;
ELECTRON CAPTURE DETECTION;
GAS CHROMATOGRAPHY;
ION MONITORING;
LIQUID LIQUID EXTRACTION;
MASS SPECTROMETRY;
PRIORITY JOURNAL;
QUALITATIVE ANALYSIS;
QUANTITATIVE ANALYSIS;
SERUM;
SILYLATION;
VALIDATION PROCESS;
GAS CHROMATOGRAPHY-MASS SPECTROMETRY;
HUMANS;
PHARMACEUTICAL PREPARATIONS;
REFERENCE STANDARDS;
SENSITIVITY AND SPECIFICITY;
|
EID: 2542479783
PISSN: 15700232
EISSN: None
Source Type: Journal
DOI: 10.1016/j.jchromb.2004.04.005 Document Type: Article |
Times cited : (112)
|
References (26)
|